New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
12:36 EDTAGN, IPXL, JNS, AMJ, SIGHigh option volume; IPXL SIG JNS AGN AMJ
News For IPXL;SIG;JNS;AGN;AMJ From The Last 14 Days
Check below for free stories on IPXL;SIG;JNS;AGN;AMJ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 21, 2014
17:07 EDTAGNValeant, Allergan deal to have $25-$30 per share of synergies, Faber says
CNBC's David Faber is reporting that Valeant's board is meeting tonight regarding a potential bid for Allergan, which it will make in combination with Bill Ackman's Pershing Square. Faber reports that the proposed combination would have about $25-$30 per share in synergies and the offer will 1/3 cash and 2/3 stock.
17:05 EDTAGNAckman reports 9.7% stake in Allergan, to consult with Valeant stake
Bill Ackman's Pershing Square disclosed in a regulatory filing that it holds a 9.7% stake in Allergan (AGN) and that it intends to consult with Valeant (VRX) on its investment. In its filing, Pershing Square said, "Valeant currently intends to propose a merger in which Allergan's shareholders will receive a combination of cash and Valeant common shares. Valeant has not yet determined the amount of cash and number of Valeant common shares it will offer, but it currently expects the cash component will total around $15B. Barclays and Royal Bank of Canada have indicated that they are prepared to deliver financing commitments covering the cash portion of the transaction at the time Valeant makes an offer." Pershing disclosed that on February 25, it entered an agreement with Valeant. As part of the deal, Pershing and Valeant agreed to for a new, jointly owned entity through which they would acquire equity in Allergan. Also, as part of that deal, Pershing Square will acquire $400M of Valeant stock at a 15% discount to current market prices immediately prior to consummation of an offer by Valeant to acquire Allergan. Shares of Allergan remain higher by more than 18% in after hours trade, while Valeant shares are up about 10%.
16:59 EDTAGNPershing Square says intends to consult with Valeant on Allergan investment
16:58 EDTAGNPershing Square says Valeant intends to propose merger with Allergan
Subscribe for More Information
16:57 EDTAGNPershing Square reports 9.7% stake in Allergan
16:40 EDTAGNValeant expected to make hostile bid for Allergan tomorrow, Faber says
Subscribe for More Information
16:38 EDTAGNAckman, Valeant team up on Allergan bid, WSJ says
Subscribe for More Information
16:26 EDTAGNValeant, Bill Ackman team up on Allergan takeover, DJ says
Subscribe for More Information
11:08 EDTAGNAllergan recent rally due to several factors, says BMO Capital
Subscribe for More Information
10:34 EDTJNSHigh option volume stocks: AXAS SCSS CPN FXEN JNS
08:58 EDTIPXLImpax appoints G. Frederick Wilkinson as CEOActavis
Subscribe for More Information
April 16, 2014
10:00 EDTIPXL, AGNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: A10 Networks (ATEN) initiated with a Buy at BofA/Merrill... Actavis (ACT) initiated with a Buy at Sterne Agee... Allergan (AGN) initiated with a Buy at Sterne Agee... Autohome (ATHM) initiated with a Neutral at Credit Suisse... BitAuto (BITA) initiated with an Outperform at Credit Suisse... Centene (CNC) initiated with a Neutral at UBS... Endo International (ENDP) initiated with a Buy at Sterne Agee... FS Investment (FSIC) initiated with an Overweight at Evercore... Hertz (HTZ) initiated with a Buy at Gabelli... Hilton (HLT) initiated with a Hold at Jefferies... Hospira (HSP) initiated with a Neutral at Sterne Agee... ImmunoGen (IMGN) initiated with a Buy at Canaccord... Impax (IPXL) initiated with a Neutral at Sterne Agee... Imperva (IMPV) assumed with a Neutral at Wedbush... Ingredion (INGR) initiated with an Outperform at Credit Suisse... Laredo Petroleum (LPI) initiated with an Outperform at RW Baird... Lpath (LPTN) initiated with a Buy at Canaccord... MediWound (MDWD) initiated with an Outperform at Oppenheimer... Medivation (MDVN) initiated with a Hold at Canaccord... NPS Pharmaceuticals (NPSP) assumed with a Buy at Canaccord... Nimble Storage (NMBL) initiated with a Market Perform at Raymond James... Regeneron (REGN) initiated with a Buy at Canaccord... Salix (SLXP) initiated with a Buy at Sterne Agee... Sibanye Gold (SBGL) initiated with an Outperform at Imperial Capital... Teva (TEVA) initiated with a Neutral at Sterne Agee... Wipro (WIT) assumed with a Hold at Jefferies.
09:15 EDTIPXLImpax launches generic Renvela for kidney disease licensed from Sanofi
Impax Laboratories (IPXL) is commencing shipment of authorized generic Renvela 800 mg tablets, through Global Pharmaceuticals, Impax's generics division. Renvela is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis. Under the terms of a settlement agreement, Sanofi (SNY) company Genzyme agreed to grant Impax a license to sell an allotment of a specified number of bottles of an authorized generic version of Renvela tablets commencing on April 16. Impax continues to pursue approval of its pending Abbreviated New Drug Application for generic Renvela with the FDA.
07:04 EDTIPXLImpax initiated with a Neutral at Sterne Agee
Subscribe for More Information
07:04 EDTAGNAllergan initiated with a Buy at Sterne Agee
Target $142.
April 14, 2014
07:43 EDTSIGSignet Jewelers potential for further upside remains, says Brean Capital
Subscribe for More Information
April 11, 2014
18:44 EDTAGNJ&J halting development of Botox competitor, WSJ says
Subscribe for More Information
07:16 EDTIPXLImpax resubmits new drug application to FDA for Rytary
Subscribe for More Information
April 10, 2014
10:47 EDTIPXL High option volume stocks: KOG PIP IPXL ADP EWH
Subscribe for More Information
07:24 EDTSIGCitigroup to hold a conference
Diamond Days Conference is being held in New York on April 10.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use